MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease — Washington D.C., District of Columbia

MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Diseases.

Sponsors: Dartmouth-Hitchcock Medical Center.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease?

MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease conducted?

MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease has 1 clinical trials on record, with 1 currently active. Their work covers Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Diseases.

Is MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease accredited by Crixeo Health?

MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.